Decentralised Trials: What Changed After the Pandemic

RG

Rachel Goldberg

Regulatory Science Advisor, Independent

Day 31:45 pm – 2:30 pmSeminar Room 2.2 (L2-SEM-2)
Part of: Digital Endpoints and Wearables in Clinical Trials (1:00 pm – 2:30 pm)

Abstract

Which remote trial practices stayed, which were abandoned, and why.

Description

Presented in “Digital Endpoints and Wearables in Clinical Trials”.

About the Speaker

RG

Rachel Goldberg

Regulatory Science Advisor, Independent

View Full Profile

Co-Speakers

HS
Hiroshi Sato

Lead, Real-World Evidence, Kansai Clinical Outcomes Network

Q&A for Decentralised Trials: What Changed After the Pandemic

Sign in to vote on questions.

Details
Duration45 min
RoomSeminar Room 2.2 (L2-SEM-2)
Tags
#live-day#research-methods
This Session

Digital Endpoints and Wearables in Clinical Trials

1:00 pm – 2:30 pm

Seminar Room 2.2

1 talk in this session

View Session
Other Talks in This Session
Validating a Wearable-Derived Endpoint

Tomasz Nowak

1:00 pm – 1:45 pm